IMCD Group’s Post

Uncover the secrets behind cutting-edge pharma manufacturing practices at the #ETREPharmaSummit as an insightful panel discussion is underway on 'Quality Metrics Transforming Pharma Manufacturing Practices.' Key Takeaways:- Alok Mehrotra, Chief Quality officer, Syngene International Limited "In the last few years have focused on root cause analysis." Dr. Damodharan Muniyandi, Chief Quality Officer, Sai Life Sciences Ltd. "FDA is pushing towards more transparency."  Shital Pathak, Sr. VP - Head Analytical R&D (Formulations), Glenmark Pharmaceuticals "We ensure quality and efficacy through CGMP." Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (Moderator) Know More: https://bit.ly/41bwcoa   #PharmaInnovation #HealthcareReform #Summit #Healthcare #IndustryLeaders #PharmaSolutions #FutureOfPharma #LiveSession

🌟 Exciting Pharma Industry Updates 🌟 1. ✅ Piramal Pharma Ltd's Ahmedabad site passes US FDA inspection, ensuring top-notch compliance! 2. 💰 Funds contest Taisho Pharmaceutical Holding Co Ltd's buyout, sparking significant industry interest. 3. 🤝 Moderna and Mitsubishi Tanabe Pharma Corporation partner in Japan, aiming to enhance healthcare innovations. 4. Daewoong Pharmaceutical's Nabota BTX approved in Argentina, expanding its global footprint! 📌 Read more news- https://lnkd.in/dh36nZ8Y 💬 Join the Conversation!  Which news stands out to you? Share your thoughts and let's discuss! 🗣️ 🔗 Stay tuned for more updates and exclusive content! #PharmaNow #PharmaNews #HealthcareInnovation #RegulatoryUpdates #IndustryPartnerships #StayTuned

Catch this webinar by our member IQVIA Asia Pacific this Thursday!

Interesting results from the research that Yuvraj Pahuja and I conducted on teleconsulting in the Indian pharmaceutical industry! 🌐🏥 We have determined Cipla's competitive advantage in the chosen market by utilizing our current advantages.🚀📊 Find out how our pharma business will grow as a result of these synergies. Making future plans for the next five years, including possible income, profitability, and the way forward. 💰💡 Have a look as we reveal a tactical approach to having an influence in this thriving industry, Cipla's growth, telemedicine success, and pharmaceutical innovation. #PharmaInnovation #TelemedicineSuccess #CiplaGrowth #Growth #CaseCompetition #CiplaAscend2

India leads in USFDA generic facility registrations with 376 for FY2024, followed by the US at 317 and China at 169. Teva Pharmaceuticals (26) led the list of companies by facility registrations, followed by AUROBINDO PHARMA LTD (22) and Viatris (18). The facility payments list under the GDUFA has revealed that as of October 30, 2023, 1,320 facilities had paid their registration fee for financial year 2024. Out of these, 663 (50%) are API facilities, 395 (30%) are FDF facilities, 68 (5%) are facilities that produce both APIs and FDFs, and 194 (15%) are CMO sites. Notably, 46 of these are newly registered facilities. Read more at: https://lnkd.in/et5-VUT9 View our dashboard: https://lnkd.in/etEEaKjH #contractmanufacturing #fda #api #fdf #cmo #FacilityRegistrations #pharma #pharmaceuticalindustry #manufacturing #gdufa #usdmf #innovation #management #digitalmarketing #technology #startups #marketing #sales #strategy #networking #pharmacompass #PharmaFlow – Generic Drug Facilities Registered with the USFDA in FY2024 - Pharma Data Compilations by PharmaCompass.com

India’s pharmaceutical sector has seen tremendous growth in recent years. It is poised to become a $130 billion industry by 2030. We are currently sending #medicines to more than 200 countries around the globe! While India is among the top three pharmaceutical leaders in terms of the volume of medicines we produce, we have shifted our focus towards achieving value leadership of late. How can we further boost our #pharma industry keeping the Viksit Bharat @ 2047 vision in mind? Share your ideas https://lnkd.in/dVdkN7bF and win! #Ideas4ViksitBharat Narendra Modi Dharmendra Pradhan Piyush Goyal Rao Inderjit Singh Suman K. Bery Confederation of Indian Industry Ministry of Commerce and Industry, Government of India

"Fueling innovation and growth! The APTI Mumbai core team came together for our annual meet, celebrating milestones achieved in 2023 and charting the course for an even more impactful 2024. Collaborating, strategizing, and paving the way for a brighter future in pharmaceutical sciences! #APTIMumbai #PharmaceuticalInnovation #Teamwork #FuturePlanning"

Rni joining ProductLife Group (PLG) makes the show, with both of our teams led by Charlène TRAVERS-CHEVALIER., PLG’s CCO, and Violaine Chaumont, RNI’s CEO, beginning to meet and enjoy collaboration, and in the press with “Pharmiweb”, “Pharmaceutical Outsourcing” and “IT for CEOs” reporting on PLG’s acquisition of RNI: Xavier Duburcq, Chief Executive Officer of ProductLife Group, says, “Thanks to RNI’s recognised regulatory expertise, we will be able to deliver an even greater value to clients”. Read more here https://bit.ly/3QjEWW8 in Pharmaceutical Outsourcing. Read also about PLG’s expansion of its Scientific And Regulatory Offering To Selfcare Products in https://lnkd.in/ekF75mH8 and https://lnkd.in/et8CJKi6 #Lifesciences #RegulatoryServices #DueDiligence #QualityAuditsHere #regulatoryaffairs #consulting #outsourcing

C-Trial Global congratulates and welcomes all generic drug players in the US market for independent monitoring of their Bioequivalence studies with best regulatory standards and successful acceptance. C-Trials Global C-Trials Global Daminee Jain #compliance #quality #bioequivalence #clinicaltrials #pkpd #biosimilars #monitoring #usfda #ema #mhra #who #anvisa #cdsco #healthcanada #tga #dcgi #clinicalresearch #gcp #pharmacovigilance #ftf #fnd #formulationdevelopment #formulations #pharmaceuticals #pharmaceuticalindustry #idma #indianpharma #phrma #pmda #usa #india #clinicaltrial #clinicaldatamanagement #regulatoryaffairs #regulatorycompliance #regulatoryintelligence #regulatoryupdates #pharma #clinical #qualityassurance #qualitymanagementsystem #qualitymatters